My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions. Conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts, with ease.
About Us
Plans & Pricing
Myomo Inc (MYO)
NYSE MKT:MYO
MYOMyomo
$12.43
$0.4 (3.33%)

Myomo Stock Analysis & Ratings

Myomo Stock Analysis Overview

Smart Score
7
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Myomo stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

MYO

MYO Stock Stats

Previous Close$12.03
Open$12.2
Bid9.33 x 200
Ask12.8 x 700
Today’s Range$12.01 - $12.43
52-Week Range$4.12 - $18.88
Volume49.14K
Average Volume76.89K
Market Cap$71.22M
Beta1.48
P/E Ratio-6.8
EPS-1.77
Earnings DateNov 08, 2021

Company Description

Myomo Inc

Myomo, Inc. is a medical robotics company, which offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. It offers MyoPro, which is a myoelectric elbow, wrist, and hand orthosis that supports an impaired hand and arm while also enabling it to move again. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Cambridge, MA.
Sector
Healthcare
Industry
Medical Devices & Instruments
CEO
Paul R. Gudonis
Employees
64
ISIN
US62857J2015
Address
137 Portland Street, Boston, MA, 02114, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

MYO FAQ

What was Myomo’s price range in the past 12 months?
Myomo lowest stock price was $4.12 and its highest was $18.88 in the past 12 months.
    What is Myomo’s market cap?
    Myomo’s market cap is $71.22M.
      What is Myomo’s price target?
      The average price target for Myomo is $17.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $17.00 ,the lowest forecast is $17.00. The average price target represents 36.77% Increase from the current price of $12.43.
        What do analysts say about Myomo?
        Myomo’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
          When is Myomo’s upcoming earnings report date?
          Myomo’s upcoming earnings report date is Nov 08, 2021 which is next month.
            How were Myomo’s earnings last quarter?
            Myomo released its earnings results on Aug 09, 2021. The company reported -$0.465 earnings per share for the quarter, beating the consensus estimate of -$0.596 by $0.131.
              Is Myomo overvalued?
              According to Wall Street analysts Myomo’s price is currently Undervalued.
                Does Myomo pay dividends?
                Myomo does not currently pay dividends.
                What is Myomo’s EPS estimate?
                Myomo’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Myomo have?
                Myomo has 5,730,000 shares outstanding.
                  What happened to Myomo’s price movement after its last earnings report?
                  Myomo reported an EPS of -$0.465 in its last earnings report, beating expectations of -$0.596. Following the earnings report the stock price went up 15.424%.
                    Which hedge fund is a major shareholder of Myomo?
                    Currently, no hedge funds are holding shares in MYO

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis